pharma · Diabetic Macular Edema · Non-infectious Uveitis Affecting the Posterior Segment of the Eye · ANIP
ANI PHARMACEUTICALS
ANI PHARMACEUTICALS INC
ANI Pharmaceuticals is a pharma organization headquartered in Princeton, USA. It trades on NYSE under ticker ANIP. Primary therapeutic focus areas include Diabetic Macular Edema, Non-infectious Uveitis Affecting the Post
500 Alexander Park, Princeton, New Jersey 08540, US HQ
678 Employees
Public company Type
ANIP · NYSE Ticker
Company details
- Status
- Public
- HQ
- 500 Alexander Park, Princeton, New Jersey 08540, US
- Employees
- 678
- Programs
- 11
- Drugs
- 7
- Patents
- 7
fluocinolone acetonide 190 micrograms
Approved · small molecule · Non-infectious Uveitis Affecting the Posterior Segment of the Eye
fluocinolone acetonide 190 micrograms for Non-infectious Uveitis Affecting the Posterior Segment of the Eye is a Approved program (small_molecule) at ANI PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).
Internal code ALI-P01-21-006
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- ANI PHARMACEUTICALS INC
- Phase
- Approved
- Modality
- small_molecule
- Indication
- Non-infectious Uveitis Affecting the Posterior Segment of the Eye
- Status
- active
- Trials
- 1